Checkpoint Inhibitor-Associated Hypophysitis

Citation metadata

Date: Jan. 2018
From: Journal of General Internal Medicine(Vol. 33, Issue 1)
Publisher: Springer
Document Type: Report
Length: 77 words

Document controls

Main content

Abstract :

To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11606-017-4135-6 Byline: Lee-Shing Chang (1), Maria A. Yialamas (2) Keywords: checkpoint inhibitors; ipilimumab; nivolumab; immunotherapy; hypophysitis Author Affiliation: (1) Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Boston, MA, USA (2) Department of Medicine, Brigham and Women's Hospital, 70 Francis St, Boston, MA, 02115, USA Article History: Registration Date: 07/07/2017 Received Date: 10/05/2017 Accepted Date: 06/07/2017 Online Date: 02/08/2017

Source Citation

Source Citation   

Gale Document Number: GALE|A521613002